Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if 10 mg BAY 59-7939, taken once daily as a tablet, is
safe and prevent blood clot which may form after total hip replacement operation.